Mechanisms, cofactors, and augmenting factors involved in anaphylaxis

Frontiers in Immunology

Volumn 8, Issue SEP, 2017, Pages

  Muñoz Cano, Rosa ^a,b   Pascal, Mariona ^a,b   Araujo, Giovanna ^a,b   Goikoetxea, M J ^c   Valero, Antonio L ^a,b   Picado, Cesar ^a,b   Bartra, Joan ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Adenosine; Anaphylaxis; Cofactor; Exercise; IgE; IgG; Mast cell; Non steroidal anti inflammatory drug

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELL RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN E; NONSTEROID ANTIINFLAMMATORY AGENT;

ALLERGIC REACTION; ANAPHYLAXIS; COMPLEMENT ACTIVATION; EXERCISE; GENETIC VARIABILITY; HUMAN; HYMENOPTERA; IMMUNE RESPONSE; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; SEX DIFFERENCE; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 85030167806     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01193     Document Type: Short Survey

References (91)

1. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol (2006) 117:391-7. doi:10.1016/j.jaci.2005.12.1303
2. Metcalfe DD, Peavy RD, Gilfillan AM. Mechanisms of mast cell signaling in anaphylaxis. J Allergy Clin Immunol (2009) 124:639-48. doi:10.1016/j.jaci.2009.08.035
3. Finkelman FD. Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol (2007) 120:506-7. doi:10.1016/j.jaci.2007.07.033
4. Strait RT, Morris SC, Yang M, Qu XW, Finkelman FD. Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol (2002) 109:658-68. doi:10.1067/mai.2002.123302
5. Muñoz-Cano R, Pascal P, Bartra J, Picado C, Valero A, Kim D, et al. Distinct transcriptome profiles differentiate nonsteroidal anti-inflammatory drug-dependent from nonsteroidal anti-inflammatory drug-independent food-induced anaphylaxis. J Allergy Clin Immunol (2016) 137:137-46. doi:10.1016/j.jaci.2015.05.042
6. Jonsson F, Daeron M. Mast cells and company. Front Immunol (2012) 3:16. doi:10.3389/fimmu.2012.00016
7. Jönsson F, Mancardi DA, Kita Y, Karasuyama H, Iannascoli B, Van Rooijen N, et al. Mouse and human neutrophils induce anaphylaxis. J Clin Invest (2011) 121:1484-96. doi:10.1172/JCI45232
8. Schroeder JT. Basophils: emerging roles in the pathogenesis of allergic disease. Immunol Rev (2011) 242:144-60. doi:10.1111/j.1600-065X.2011.01023.x
9. Santos AF, Du Toit G, Douiri A, Radulovic S, Stephens A, Turcanu V, et al. Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut. J Allergy Clin Immunol (2015) 135:179-86. doi:10.1016/j.jaci.2014.09.001
10. Korosec P, Turner PJ, Silar M, Kopac P, Kosnik M, Gibbs BF, et al. Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis. J Allergy Clin Immunol (2017) 140:750-8. doi:10.1016/j.jaci.2016.12.989
11. Rivera J, Gilfillan A. Molecular regulation of mast cell activation. J Allergy Clin Immunol (2006) 117:1214-25. doi:10.1016/j.jaci.2006.04.015
12. Kajiwara N, Sasaki T, Bradding P, Cruse G, Sagara H, Ohmori K, et al. Activation of human mast cells through the platelet-activating factor receptor. J Allergy Clin Immunol (2010) 125:1137-45.e6. doi:10.1016/j.jaci.2010.01.056
13. Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, et al. Mast cells and inflammation. Biochim Biophys Acta (2012) 1822:21-33. doi:10.1016/j.bbadis.2010.12.014
14. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol (2002) 110:341-8. doi:10.1067/mai.2002.126811
15. Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol (2006) 6:218-30. doi:10.1038/nri1782
16. Bruhns P. Properties of mouse and human IgG receptors and their contribution to disease models. Blood (2012) 119:5640-9. doi:10.1182/blood-2012-01-380121
17. Beutier H, Gillis CM, Iannascoli B, Godon O, England P, Sibilano R, et al. IgG subclasses determine pathways of anaphylaxis in mice. J Allergy Clin Immunol (2017) 139:269-80.e7. doi:10.1016/j.jaci.2016.03.028
18. Tsujimura Y, Obata K, Mukai K, Shindou H, Yoshida M, Nishikado H, et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity (2008) 28:581-9. doi:10.1016/j.immuni.2008.02.008
19. Vadas P, Gold M, Perelman B, Liss GM, Lack G, Blyth T, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med (2008) 358:28-35. doi:10.1056/NEJMoa070030
20. Stafforini DM. Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2). Cardiovasc Drugs Ther (2009) 23:73-83. doi:10.1007/s10557-008-6133-8
21. Brown SGA, Stone SF, Fatovich DM, Burrows SA, Holdgate A, Celenza A, et al. Anaphylaxis: clinical patterns, mediator release, and severity. J Allergy Clin Immunol (2013) 132:1141-9.e5. doi:10.1016/j.jaci.2013.06.015
22. Okayama Y, Hagaman DD, Metcalfe DD. A comparison of mediators released or generated by IFN-γ-treated human mast cells following aggregation of FcγRI or FceRI1. J Immunol (2001) 166:4705-12. doi:10.4049/jimmunol.166.7.4705
23. Woolhiser MR, Brockow K, Metcalfe DD. Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a. Clin Immunol (2004) 110:172-80. doi:10.1016/j.clim.2003.11.007
24. Rispens T, Derksen NIL, Commins SP, Platts-Mills TA, Aalberse RC. IgE production to a-gal is accompanied by elevated levels of specific IgG1 antibodies and low amounts of IgE to blood group B. PLoS One (2013) 8:e55566. doi:10.1371/journal.pone.0055566
25. DeNichilo MO, Stewart AG, Vadas MA, Lopez AF. Granulocyte-macrophage colony-stimulating factor is a stimulant of platelet-activating factor and superoxide anion generation by human neutrophils. J Biol Chem (1991) 266:4896-902.
26. Francis A, Bosio E, Stone SF, Fatovich DM, Arendts G, Nagree Y, et al. Neutrophil activation during acute human anaphylaxis: analysis of MPO and sCD62L. Clin Exp Allergy (2017) 47:361-70. doi:10.1111/cea.12868
27. Mancardi DA, Albanesi M, Jönsson F, Iannascoli B, Van Rooijen N, Kang X, et al. The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy. Blood (2013) 121:1563-73. doi:10.1182/blood-2012-07-442541
28. van der Poel CE, Spaapen RM, van de Winkel JGJ, Leusen JHW. Functional characteristics of the high affinity IgG receptor, FcγRI. J Immunol (2011) 186:2699-704. doi:10.4049/jimmunol.1003526
29. Zwirner J, Götze O, Sieber A, Kapp A, Begemann G, Zuberbier T, et al. The human mast cell line HMC-1 binds and responds to C3a but not C3a(desArg). Scand J Immunol (1998) 47:19-24. doi:10.1046/j.1365-3083.1998.00250.x
30. Khodoun M, Strait R, Orekov T, Hogan S, Karasuyama H, Herbert DR, et al. Peanuts can contribute to anaphylactic shock by activating complement. J Allergy Clin Immunol (2009) 123:342-51. doi:10.1016/j.jaci.2008.11.004
31. Wölbing F, Fischer J, Köberle M, Kaesler S, Biedermann T. About the role and underlying mechanisms of cofactors in anaphylaxis. Allergy (2013) 68:1085-92. doi:10.1111/all.12193
32. Szebeni J, Muggia FM, Alving CR. Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J Natl Cancer Inst (1998) 90:300-6. doi:10.1093/jnci/90.4.300
33. Kawabata Y, Yang TS, Yokochi TT, Matsushita M, Fujita T, Shibazaki M, et al. Complement system is involved in anaphylactoid reaction induced by lipopolysaccharides in muramyldipeptide-treated mice. Shock (2000) 14:572-7. doi:10.1097/00024382-200014050-00013
34. Rodriguez MJ, Aranda A, Fernandez TD, Cubells-Baeza N, Torres MJ, Gomez F, et al. LPS promotes Th2 dependent sensitisation leading to anaphylaxis in a Pru p 3 mouse model. Sci Rep (2017) 7:40449. doi:10.1038/srep40449
35. Pinckard RN, Tanigawa C, Halonen M. IgE-induced blood coagulation alterations in the rabbit: consumption of coagulation factors XII, XI, and IX in vivo. J Immunol (1975) 115:525-32.
36. Sala-Cunill A, Björkqvist J, Senter R, Guilarte M, Cardona V, Labrador M, et al. Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions. J Allergy Clin Immunol (2015) 135:1031-43.e6. doi:10.1016/j.jaci.2014.07.057
37. Guerrini M, Beccati D, Shriver Z, Naggi A, Viswanathan K, Bisio A, et al. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol (2008) 26:669-75. doi:10.1038/nbt1407
38. Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med (2008) 358:2457-67. doi:10.1056/NEJMoa0803200
39. Siebeck M, Cheronis JC, Fink E, Kohl J, Spies B, Spannagl M, et al. Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors. J Appl Physiol (1994) 77:2675-80.
40. McNeil BD, Pundir P, Meeker S, Han L, Undem BJ, Kulka M, et al. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature (2015) 519:237-41. doi:10.1038/nature14022
41. Worm M, Edenharter G, RuëffF, Scherer K, Pföhler C, Mahler V, et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy (2012) 67:691-8. doi:10.1111/j.1398-9995.2012.02795.x
42. Niggemann B, Beyer K. Factors augmenting allergic reactions. Allergy (2014) 69:1582-7. doi:10.1111/all.12532
43. Webb LM, Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol (2006) 97(1):39-43. doi:10.1016/S1081-1206(10)61367-1
44. Liew WK, Williamson E, Tang MLK. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol (2009) 123:434-42. doi:10.1016/j.jaci.2008.10.049
45. Pereira Vega A, Sanchez Ramos JL, Maldonado Perez JA, Alvarez Gutierrez FJ, Ignacio Garcia JM, Vazquez Oliva R, et al. Variability in the prevalence of premenstrual asthma. Eur Respir J (2010) 35:980-6. doi:10.1183/09031936.00045109
46. Vasconcelos C, Xavier P, Vieira AP, Martinho M, Rodrigues J, Bodas A, et al. Autoimmune progesterone urticaria. Gynecol Endocrinol (2000) 14:245-7. doi:10.3109/09513590009167688
47. Bauer CS, Kampitak T, Messieh ML, Kelly KJ, Vadas P. Heterogeneity in presentation and treatment of catamenial anaphylaxis. Ann Allergy Asthma Immunol (2013) 111:107-11. doi:10.1016/j.anai.2013.06.001
48. Hox V, Desai A, Bandara G, Gilfillan AM, Metcalfe DD, Olivera A. Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric oxide synthase expression and nitric oxide production. J Allergy Clin Immunol (2015) 135:729-36.e5. doi:10.1016/j.jaci.2014.11.003
49. Versluis A, van Os-Medendorp H, Kruizinga AG, Blom WM, Houben GF, Knulst AC. Cofactors in allergic reactions to food: physical exercise and alcohol are the most important. Immun Inflamm Dis (2016) 4:392-400. doi:10.1002/iid3.120
50. Morita E, Kunie K, Matsuo H. Food-dependent exercise-induced anaphylaxis. J Dermatol Sci (2007) 47:109-17. doi:10.1016/j.jdermsci.2007.03.004
51. Palosuo K, Varjonen E, Nurkkala J, Kalkkinen N, Harvima R, Reunala T, et al. Transglutaminase-mediated cross-linking of a peptic fraction of ω-5 gliadin enhances IgE reactivity in wheat-dependent, exercise-induced anaphylaxis. J Allergy Clin Immunol (2003) 111:1386-92. doi:10.1067/mai.2003.1498
52. Lambert GP, Broussard LJ, Mason BL, Mauermann WJ, GisolfiCV. Gastrointestinal permeability during exercise: effects of aspirin and energy-containing beverages. J Appl Physiol (2001) 90(6):2075-80.
53. Matsuo H, Morimoto K, Akaki T, Kaneko S, Kusatake K, Kuroda T, et al. Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy (2005) 35:461-6. doi:10.1111/j.1365-2222.2005.02213.x
54. Sakamoto Y, Ohtsuka T, Yoshida H, Ohto K, Onobori M, Matsumoto T, et al. Time course of changes in the intestinal permeability of food-sensitized rats after oral allergen challenge. Pediatr Allergy Immunol (1998) 9:20-4. doi:10.1111/j.1399-3038.1998.tb00295.x
55. Yano H, Kato Y, Matsuda T. Acute exercise induces gastrointestinal leakage of allergen in lysozyme-sensitized mice. Eur J Appl Physiol (2002) 87:358-64. doi:10.1007/s00421-002-0653-x
56. Phillips TLE, Phillips TLE, Neutra MR. Macromolecules can pass through occluding junctions of rat ileal epithelium during cholinergic stimulation. Cell Tissue Res (1987) 247:547-54. doi:10.1007/BF00215748
57. Zuhl M, Schneider S, Lanphere K, Conn C, Dokladny K, Moseley P. Exercise regulation of intestinal tight junction proteins. Br J Sports Med (2014) 48:980-6. doi:10.1136/bjsports-2012-091585
58. KhKhamnei S, Alipour MR, Ahmadiasl N. The combined effects of exercise and post dehydration water drinking on plasma argenine vasopressin, plasma osmolality and body temperature in healthy males. Int J Endocrinol Metab (2005) 2:80-6.
59. Torres-Atencio I, Ainsua-Enrich E, de Mora F, Picado C, Martín M. Prostaglandin E2 prevents hyperosmolar-induced human mast cell activation through prostanoid receptors EP2 and EP4. PLoS One (2014) 9:e110870. doi:10.1371/journal.pone.0110870
60. Eggleston PA, Kagey-Sobotka A, Schleimer RP, Lichtenstein LM. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis (1984) 130:86-91.
61. Caslake MJ, Packard CJ, Suckling KE, Holmes SD, Chamberlain P, Macphee CH. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis (2000) 150:413-9. doi:10.1016/S0021-9150(99)00406-2
62. Perelman B, Adil A, Vadas P. Relationship between platelet activating factor acetylhydrolase activity and apolipoprotein B levels in patients with peanut allergy. Allergy Asthma Clin Immunol (2014) 10:20. doi:10.1186/1710-1492-10-20
63. Moneret-Vautrin D-A, Latarche C. Drugs as risk factors of food anaphylaxis in adults: a case-control study. Bull Acad Natl Med (2009) 193(2):351-62; discussion 362-3.
64. Cardona V, Luengo O, Garriga T, Labrador-Horrillo M, Sala-Cunill A, Izquierdo A, et al. Co-factor-enhanced food allergy. Allergy (2012) 67:1316-8. doi:10.1111/j.1398-9995.2012.02877.x
65. Pascal M, Muñoz-Cano R, Reina Z, Palacín A, Vilella R, Picado C, et al. Lipid transfer protein syndrome: clinical pattern, cofactor effect and profile of molecular sensitization to plant-foods and pollens. Clin Exp Allergy (2012) 42:1529-39. doi:10.1111/j.1365-2222.2012.04071.x
66. Wallace JL, de Nucci G, Sulaieva O. Toward more GI-friendly anti-inflammatory medications. Curr Treat Options Gastroenterol (2015) 13:377-85. doi:10.1007/s11938-015-0064-9
67. Bjarnason I, Takeuchi K. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. J Gastroenterol (2009) 44:23-9. doi:10.1007/s00535-008-2266-6
68. Matsukura S, Aihara M, Sugawara M, Kunimi Y, Matsuki M, Inoue Y, et al. Two cases of wheat-dependent anaphylaxis induced by aspirin administration but not by exercise. Clin Exp Dermatol (2010) 35:233-7. doi:10.1111/j.1365-2230.2009.03709.x
69. Aihara M, Miyazawa M, Osuna H, Tsubaki K, Ikebe T, Aihara Y, et al. Food-dependent exercise-induced anaphylaxis: influence of concurrent aspirin administration on skin testing and provocation. Br J Dermatol (2002) 146:466-72. doi:10.1046/j.1365-2133.2002.04601.x
70. Pascal M, Muñoz-Cano R, Milà J, Sanz ML, Diaz-Perales A, Sánchez-López J, et al. Nonsteroidal anti-inflammatory drugs enhance IgE-mediated activation of human basophils in patients with food anaphylaxis dependent on and independent of nonsteroidal anti-inflammatory drugs. Clin Exp Allergy (2016) 46:1111-9. doi:10.1111/cea.12735
71. Wojnar RJ, Hearn T, Starkweather S. Augmentation of allergic histamine release from human leukocytes by nonsteroidal anti-inflammatory-analgesic agents. J Allergy Clin Immunol (1980) 66:37-45. doi:10.1016/0091-6749(80)90136-0
72. Kowalski ML, Asero R, Bavbek S, Blanca M, Blanca-Lopez N, Bochenek G, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy (2013) 68:1219-32. doi:10.1111/all.12260
73. Knights KM, Mangoni AA, Miners JO. Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity. Expert Rev Clin Pharmacol (2010) 3:769-76. doi:10.1586/ecp.10.120
74. Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev (2004) 56:387-437. doi:10.1124/pr.56.3.3
75. Takahashi A, Nakajima K, Ikeda M, Sano S, Takahashi A, Nakajima K, et al. Pre-treatment with misoprostol prevents food-dependent exercise-induced anaphylaxis (FDEIA). Int J Dermatol (2011) 50:233-40. doi:10.1111/j.1365-4632.2010.04314.x
76. Kim SH, Nam EJ, Kim YK, Ye YM, Park HS. Functional variability of the adenosine A3 receptor (ADORA3) gene polymorphism in aspirin-induced urticaria. Br J Dermatol (2010) 163:977-85. doi:10.1111/j.1365-2133.2010.09983.x
77. Kim SH, Kim YK, Park HW, Ye YM, Min KU, Park HS. Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma. Respir Med (2009) 103:356-63. doi:10.1016/j.rmed.2008.10.008
78. Jin X, Shepherd RK, Duling BR, Linden J. Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest (1997) 100:2849-57. doi:10.1172/JCI119833
79. Leung CT, Li A, Banerjee J, Gao Z-GG, Kambayashi T, Jacobson KA, et al. The role of activated adenosine receptors in degranulation of human LAD2 mast cells. Purinergic Signal (2014) 10:1-11. doi:10.1007/s11302-014-9409-4
80. Ramkumar V, Stiles GL, Beaven MA, Ali H. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem (1993) 268:16887-90.
81. Miyahara JT, Karler R. Effect of salicylate on oxidative phosphorylation and respiration of mitochondrial fragments. Biochem J (1965) 97:194-8. doi:10.1042/bj0970194
82. Cronstein BN, Vandestouwe M, Druska L, Levin RI, Weissmann G. Nonsteroidal antiinflammatory agents inhibit stimulated neutrophil adhesion to endothelium-adenosine-dependent and independent mechanisms. Inflammation (1994) 18:323-35. doi:10.1007/BF01534273
83. Jacobs RL, Rake GW, Fournier DC, Chilton RJ, Culver WG, Beckmann CH. Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade. J Allergy Clin Immunol (1981) 68:125-7. doi:10.1016/0091-6749(81)90170-6
84. RuëffF, Przybilla B, Biló MB, Müller U, Scheipl F, Aberer W, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on insect venom hypersensitivity. J Allergy Clin Immunol (2009) 124(5):1047-54. doi:10.1016/j.jaci.2009.08.027
85. Brown SGA. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol (2004) 114:371-6. doi:10.1016/j.jaci.2004.04.029
86. Nassiri M, Babina M, Dölle S, Edenharter G, RuëffF, Worm M. Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming. J Allergy Clin Immunol (2015) 135(2):491-9. doi:10.1016/j.jaci.2014.09.004
87. Zogaj D, Ibranji A, Hoxha M. Exercise-induced anaphylaxis: the role of cofactors. Mater Sociomed (2014) 26:401-4. doi:10.5455/msm.2014.26.401-404
88. Wang Y, Tong J, Chang B, Wang B, Zhang D, Wang B. Effects of alcohol on intestinal epithelial barrier permeability and expression of tight junction-associated proteins. Mol Med Rep (2014) 9:2352-6. doi:10.3892/mmr.2014.2126
89. Nagy LE, Diamond I, Casso DJ, Franklin C, Gordon AS. Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J Biol Chem (1990) 265:1946-51.
90. Alonso M, Gomez-Rial J, Gude F, Vidal C, Gonzalez-Quintela A. Influence of experimental alcohol administration on serum immunoglobulin levels: contrasting effects on IgE and other immunoglobulin classes. Int J Immunopathol Pharmacol (2012) 25:645-55. doi:10.1177/039463201202500311
91. Heinz R, Waltenbaugh C. Ethanol consumption modifies dendritic cell antigen presentation in mice. Alcohol Clin Exp Res (2007) 31:1759-71. doi:10.1111/j.1530-0277.2007.00479.x